|
ZNF655 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27219998372163E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.30239999790649E-08 |
| Normal-vs-Stage2 |
6.961200E-04 |
| Normal-vs-Stage3 |
2.1428000485102E-09 |
| Normal-vs-Stage4 |
2.04150000238101E-08 |
| Stage1-vs-Stage2 |
5.821000E-01 |
| Stage1-vs-Stage3 |
4.073700E-02 |
| Stage1-vs-Stage4 |
4.773600E-02 |
| Stage2-vs-Stage3 |
8.690100E-02 |
| Stage2-vs-Stage4 |
7.934300E-02 |
| Stage3-vs-Stage4 |
7.261200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.20720000452002E-09 |
| Normal-vs-AfricanAmerican |
6.20839999999623E-05 |
| Normal-vs-Asian |
1.641060E-04 |
| Caucasian-vs-AfricanAmerican |
8.837000E-01 |
| Caucasian-vs-Asian |
2.496400E-01 |
| AfricanAmerican-vs-Asian |
3.400400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.5380999957878E-08 |
| Normal-vs-Female |
6.46870002007915E-09 |
| Male-vs-Female |
7.856200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.58309999945361E-07 |
| Normal-vs-Age(41-60Yrs) |
8.08279999597872E-08 |
| Normal-vs-Age(61-80Yrs) |
1.53089999566092E-08 |
| Normal-vs-Age(81-100Yrs) |
3.401500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.663400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.066220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.900750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.268200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.663000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.321000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.552300E-04 |
| Classical-VS-Follicular |
1.272600E-01 |
| Classical-VS-Other |
1.546030E-01 |
| Classical-VS-Normal |
3.44509999972153E-07 |
| Tall-VS-Follicular |
5.632000E-02 |
| Tall-VS-Other |
8.726600E-01 |
| Tall-VS-Normal |
1.45620004943225E-09 |
| Follicular-VS-Other |
4.740600E-01 |
| Follicular-VS-Normal |
6.63819999968673E-07 |
| Other-VS-Normal |
7.017100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.82100004151454E-09 |
| Normal-vs-N1 |
2.80620000003839E-06 |
| N0-vs-N1 |
7.534200E-01 |
|
|
